{"type":"trials","record":{"id":35794,"source_id":"clinicaltrials-gov","external_id":"NCT07315789","title":"Effects of a Strength Training Programme in Institutionalized Older Adults With Sarcopenia.","brief_summary":"Sarcopenia is one of the main problems in the elderly population. The concept of disease has evolved, as have its treatment strategies. Among these is high-intensity interval training (HIIT). This approach has been little studied in older adults with sarcopenia, especially in institutionalized older adults in nursing homes. So this will be the objective of the study. A randomised clinical trial is being conducted to analyse how these diagnostic criteria for sarcopenia evolve after the application of HIIT compared to a control group.","overall_status":"Completed","phases":[],"study_type":"INTERVENTIONAL","sponsor":"University of Extremadura","enrollment":164,"countries":["Spain"],"start_date":"2022-02-01","completion_date":"2025-12-15","last_update_date":"2026-03-17","source_url":"https://clinicaltrials.gov/study/NCT07315789","editorial_summary":"A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.","first_seen_at":"2026-09-25T01:20:24.196666+00:00","last_seen_at":"2026-09-25T06:10:25.747+00:00","metadata":{"sex":"ALL","acronym":null,"age_range":"60 Years","comparator":"This group includes institutionalized older adults aged 60 and over.","organization":"University of Extremadura","interventions":["High-intensity interval strength training: therapeutic exercise programme."],"registry_source":"ClinicalTrials.gov","outcome_measures":["Hand grip strenght — Thrice at the baseline: at the start, at 8 weeks and at 12 weeks.","Muscular mass / appendicular skeletal mass (ASM) — Thrice at the baseline: at the start, at 8 weeks and at 12 weeks.","Physical performance — Thrice at the baseline: at the start, at 8 weeks and at 12 weeks.","Physical performance 2 — Thrice at the baseline: at the start, at 8 weeks and at 12 weeks."],"design_description":"RANDOMIZED · PARALLEL · TREATMENT · QUADRUPLE","source_has_results":false},"controlled_terms":["Sarcopenia in Elderly","Institutionalized Older Adults","HIIT","High-intensity interval strength training: therapeutic exercise programme."],"relevance_confidence":100,"source_quality_score":100,"freshness_score":85,"publication_state":"published","match_explanation":"Title contains controlled term: strength training.","quality_checked_at":"2026-09-25T06:10:37.875473+00:00","duplicate_cluster_key":"id:nct07315789","duplicate_of_id":null,"evidence_snapshot":{"status":"structured","version":1,"duration":"2022-02-01 to 2025-12-15","comparator":"This group includes institutionalized older adults aged 60 and over.","confidence":"structured-source","population":"ALL · 60 Years","provenance":{"duration":"start_date and completion_date","comparator":"registry arm fields","population":"registry eligibility fields","intervention":"registry intervention fields","participants":"enrollment","study_design":"study_type and registry design fields","evidence_stage":"phases","reported_outcome":"not available","outcomes_measured":"registry outcome-measure fields"},"generated_at":"2026-09-25T06:10:25.795Z","intervention":["High-intensity interval strength training: therapeutic exercise programme."],"participants":164,"study_design":"RANDOMIZED · PARALLEL · TREATMENT · QUADRUPLE","subject_scope":"Human clinical study registration","evidence_stage":"Phase not reported","safety_context":"Eligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians.","source_support":"Structured registry protocol metadata; no finding-level conclusion is generated.","main_limitation":"This is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.","reported_outcome":null,"outcomes_measured":["Hand grip strenght — Thrice at the baseline: at the start, at 8 weeks and at 12 weeks.","Muscular mass / appendicular skeletal mass (ASM) — Thrice at the baseline: at the start, at 8 weeks and at 12 weeks.","Physical performance — Thrice at the baseline: at the start, at 8 weeks and at 12 weeks.","Physical performance 2 — Thrice at the baseline: at the start, at 8 weeks and at 12 weeks."],"regulatory_context":"Trial registration is not regulatory approval and does not establish that an intervention is available."},"clinical_trial_topics":[{"topic_slug":"resistance-training","is_published":true,"match_reasons":["Title contains controlled term: strength training.","Source terminology contains: strength training.","Title supplies longevity context: older adult.","Study type is explicitly identified as INTERVENTIONAL."],"matched_fields":["title","controlled terminology","title context","study type"],"relevance_score":100,"intelligence_topics":{"name":"Resistance training","slug":"resistance-training"}},{"topic_slug":"sarcopenia","is_published":true,"match_reasons":["Title contains controlled term: sarcopenia.","Abstract contains controlled term: sarcopenia.","Source terminology contains: sarcopenia.","Title supplies longevity context: older adult.","Study type is explicitly identified as INTERVENTIONAL."],"matched_fields":["title","abstract","controlled terminology","title context","study type"],"relevance_score":100,"intelligence_topics":{"name":"Sarcopenia","slug":"sarcopenia"}}],"content_sources":{"name":"ClinicalTrials.gov","homepage_url":"https://clinicaltrials.gov/"}},"canonical_url":"https://www.immortal.life/trials/35794","automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}